Diagnostics and treatment of female urinary incontinence

被引：1

作者：

von Hobe A.-K. ^{[1
]}

Kohlschein B. ^{[1
]}

Dimpfl T. ^{[1
]}

机构：

[1] Frauenklinik, Klinikum Kassel, Mönchebergstraße 41–43, Kassel

来源：

Der Gynäkologe | 2018年 / 51卷 / 11期

关键词：

Conservative treatment; Surgical treatment approaches; Urinary bladder; overactive; Urinary incontinence; stress; Urodynamic measurement;

D O I：

10.1007/s00129-018-4323-4

中图分类号：

学科分类号：

摘要：

Female urinary incontinence is a significant health topic, which in today’s society is still considered a taboo subject. It has a detrimental impact on women’s daily routine and can immensely reduce the quality of life. Most patients suffering from incontinence do not reach out for medical advice as incontinence is still seen as an incurable disease related to aging. Approximately 28% of women above the age of 20 years old suffer from urinary incontinence; however, accurate diagnostics and initiation of sufficient treatment have shown satisfactory results for women in approximately 90% of the cases. © 2018, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

引用

页码：959 / 971

页数：12

共 19 条

[1]

Minassian V.A., Devore E., Hagan K., Grodstein F., Severity of urinary incontinence and effekt on quality of life in women by incontinence type, Obstet Gynecol, 121, 5, pp. 1083-1090, (2013)

[2]

Abrams P., Feneley R., Torres M., Urodynamik für Klinik und Praxis, (1987)

[3]

Geirsson G., Lindstrom S., Fall M., The bladder cooling refkex and the use of cooling as stimulus tot he lower urinary tract, J. Urol., 162, 6, pp. 1890-1896, (1999)

[4]

Cody J.D., Et al., Oestrogen therapy for urinary incontinence in postmenopausal women, Cochrane Database Syst Rev, 10, (2012)

[5]

„Mirabegron – Was kann der Beta3-Agonist?“, Frauenarzt, 8, pp. 692-697, (2015)

[6]

(2018)

[7]

(2018)

[8]

Markland A.D., Richter H.E., Kenton K.S., Wal C., Nager C.W., Kraus S.R., Xu Y., Tennstedt S.L., Urinary Incontinence Treatment Network. Associated factors and the impact of fecal incontinence in women with urge urinary incontinence, Am J Obstet Gynecol, 200, 4, pp. 424.e1-424.e8, (2009)

[9]

Coyne K.S., Cash B., Kopp Z., Gelhorn H., Milsom I., Berriman S., Vats V., Khullar V., The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder, BJU Int, 107, 2, pp. 254-261, (2011)

[10]

Leng W.W., Chancellor M.B., How sacral nerve stimulation neuromodulation works, Ulol Clin N Am, 33, pp. 11-18, (2005)

← 1 2 →